Aehr Test Systems Reports 30% Revenue Growth for Fiscal Year 2017 and Provides Financial Guidance for Fiscal 2018
|
AEHR TEST SYSTEMS AND SUBSIDIARIES |
|
Reconciliation of GAAP and Non-GAAP Results |
| (in thousands, except per share data) |
| (unaudited) |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | Three Months Ended | | Year Ended |
| | | May 31, | | Feb 28, | | May 31, | | May 31, | | May 31, |
| | | | 2017 | | | | 2017 | | | | 2016 | | | | 2017 | | | | 2016 | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| GAAP net loss | | $ | (795 | ) | | $ | (2,651 | ) | | $ | (3,056 | ) | | $ | (5,653 | ) | | $ | (6,785 | ) |
| Stock-based compensation expense | | | 208 | | | | 257 | | | | 230 | | | | 999 | | | | 1,016 | |
| Non-GAAP net loss | | $ | (587 | ) | | $ | (2,394 | ) | | $ | (2,826 | ) | | $ | (4,654 | ) | | $ | (5,769 | ) |
| | | | | | | | | | | |
| GAAP net loss per diluted share | | $ | (0.04 | ) | | $ | (0.16 | ) | | $ | (0.23 | ) | | $ | (0.35 | ) | | $ | (0.52 | ) |
| Non-GAAP net loss per diluted share | | $ | (0.03 | ) | | $ | (0.14 | ) | | $ | (0.21 | ) | | $ | (0.29 | ) | | $ | (0.44 | ) |
| Shares used in diluted shares calculation | | | 19,050 | | | | 16,672 | | | | 13,190 | | | | 16,267 | | | | 13,091 | |
| Shares used in non-GAAP diluted shares calculation | | | 19,050 | | | | 16,672 | | | | 13,190 | | | | 16,267 | | | | 13,091 | |
| | |
| | | | | | | | | | | |
Non-GAAP net loss is a non-GAAP measure and should not be considered a replacement for GAAP results. Non-GAAP net loss is a financial measure the Company uses to evaluate the underlying results and operating performance of the business. The limitation of this measure is that it excludes items that impact the Company's current period net loss. This limitation is best addressed by using this measure in combination with net loss (the most directly comparable GAAP financial measure). These measures are not in accordance with GAAP and may differ from non-GAAP methods of accounting and reporting used by other companies.
We believe these measures enhance investors’ ability to review the company’s business from the same perspective as the company’s management and facilitate comparisons of this period’s results with prior periods. |
| |
